| Accession |
PRJCA012477 |
| Title |
A Phase I/II, Open Label, Multicenter Study to Assess Safety and Anti-tumor Efficacy of DZD8586 in Patients with B-NHL |
| Relevance |
Medical |
| Data types |
PK data
|
| Organisms |
Homo sapiens
|
| Description |
The study consists of two parts: part A, the dose escalation phase that aims to establish RP2D, and part B, the dose expansion phase that includes six cohorts. The primary objective of the study is to define RP2D, evaluate anti-tumor efficacy, safety and tolerability. |
| Sample scope |
Multiisolate |
| Release date |
2024-10-13 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Yuqin
Song (SongYQ_VIP@163.com)
|
| Organization |
Peking University Cancer Hospital & Institute |
| Submission date |
2022-10-13 |
